Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Pollack

Showing results (21-30 of 265) with videos related to

Pageof 27
Sort By:
The Prostate|June 4, 2004
Antisense MDM2 oligonucleotides restore the apoptotic response of prostate cancer cells to androgen deprivationZhaomei Mu, Paul Hachem, Sudhir Agrawal, et al.
Seminars in Cancer Biology|January 9, 2026
Lipid Dysregulation in Renal Cancer: Drivers of Tumor Growth and Determinants of Treatment-Induced ToxicityMohammed Alnukhali, Alessia Fornoni, Alan Pollack, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2004
Antisense MDM2 sensitizes prostate cancer cells to androgen deprivation, radiation, and the combinationZhaomei Mu, Paul Hachem, Sudhir Agrawal, et al.
Urology|September 17, 2002
Impact of androgen deprivation therapy on survival in men treated with radiation for prostate cancerAlan Pollack, Deborah A Kuban, Gunar K Zagars
ACS Pharmacology & Translational Science|September 19, 2024
Lipid Metabolism Modulatory Cisplatin Prodrug Sensitizes Resistant Prostate Cancer toward Androgen Deprivation TherapySubham Guin, Akash Ashokan, Alan Pollack, et al.
Psychology, Health & Medicine|March 20, 2008
Longitudinal associations among quality of life and its predictors in patients treated for prostate cancer: the moderating role of ageMichael Diefenbach, Nihal Elamin Mohamed, Eric Horwitz, et al.
Translational Andrology and Urology|July 28, 2018
Contemporary role of postoperative radiotherapy for prostate cancerAlan Dal Pra, Matthew C Abramowitz, Radka Stoyanova, et al.
The Urologic Clinics of North America|May 9, 2003
Mindless or mindful? Radiation oncologists' perspectives on the evolution of prostate cancer treatmentAlan Pollack, Eric M Horwitz, Benjamin Movsas, et al.
International Journal of Radiation Oncology, Biology, Physics|October 9, 2007
Interval to biochemical failure highly prognostic for distant metastasis and prostate cancer-specific mortality after radiotherapyMark K Buyyounouski, Alexandra L Hanlon, Eric M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2003
Short-term androgen deprivation and PSA doubling time: their association and relationship to disease progression after radiation therapy for prostate cancerAlexandra L Hanlon, Eric M Horwitz, Gerald E Hanks, et al.
Pageof 27

Showing results (21-30 of 265) with videos related to

Sort By:
Pageof 27
The Prostate|June 4, 2004
Antisense MDM2 oligonucleotides restore the apoptotic response of prostate cancer cells to androgen deprivationZhaomei Mu, Paul Hachem, Sudhir Agrawal, et al.
Seminars in Cancer Biology|January 9, 2026
Lipid Dysregulation in Renal Cancer: Drivers of Tumor Growth and Determinants of Treatment-Induced ToxicityMohammed Alnukhali, Alessia Fornoni, Alan Pollack, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2004
Antisense MDM2 sensitizes prostate cancer cells to androgen deprivation, radiation, and the combinationZhaomei Mu, Paul Hachem, Sudhir Agrawal, et al.
Urology|September 17, 2002
Impact of androgen deprivation therapy on survival in men treated with radiation for prostate cancerAlan Pollack, Deborah A Kuban, Gunar K Zagars
ACS Pharmacology & Translational Science|September 19, 2024
Lipid Metabolism Modulatory Cisplatin Prodrug Sensitizes Resistant Prostate Cancer toward Androgen Deprivation TherapySubham Guin, Akash Ashokan, Alan Pollack, et al.
Psychology, Health & Medicine|March 20, 2008
Longitudinal associations among quality of life and its predictors in patients treated for prostate cancer: the moderating role of ageMichael Diefenbach, Nihal Elamin Mohamed, Eric Horwitz, et al.
Translational Andrology and Urology|July 28, 2018
Contemporary role of postoperative radiotherapy for prostate cancerAlan Dal Pra, Matthew C Abramowitz, Radka Stoyanova, et al.
The Urologic Clinics of North America|May 9, 2003
Mindless or mindful? Radiation oncologists' perspectives on the evolution of prostate cancer treatmentAlan Pollack, Eric M Horwitz, Benjamin Movsas, et al.
International Journal of Radiation Oncology, Biology, Physics|October 9, 2007
Interval to biochemical failure highly prognostic for distant metastasis and prostate cancer-specific mortality after radiotherapyMark K Buyyounouski, Alexandra L Hanlon, Eric M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2003
Short-term androgen deprivation and PSA doubling time: their association and relationship to disease progression after radiation therapy for prostate cancerAlexandra L Hanlon, Eric M Horwitz, Gerald E Hanks, et al.
Pageof 27